Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GLR2007 |
Synonyms | |
Therapy Description |
GLR2007 is a selective inhibitor of CDK4 and CDK6 that can cross blood-brain-barrier, and may result in inhibition of tumor growth (J Clin Oncol 39, no. 15_suppl, abstract e14023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GLR2007 | GLR-2007|GLR 2007|GLR2007-237FA|GLR-2007-237FA|GLR 2007-237FA | CDK4/6 Inhibitor 14 | GLR2007 is a selective inhibitor of CDK4 and CDK6 that can cross blood-brain-barrier, and may result in inhibition of tumor growth (J Clin Oncol 39, no. 15_suppl, abstract e14023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04444427 | Phase Ib/II | GLR2007 | Evaluation of GLR2007 for Advanced Solid Tumors | Completed | USA | 0 |